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It has been estimated that 300–500 million malaria infections occur on an annual basis and causes fatality to millions of human
beings. Most of the drugs used for treatment of malaria have developed drug-resistant parasites or have serious side eﬀects. Plant
kingdom has throughout the centuries proved to be eﬃcient source of eﬃcacious malarial drugs like quinine and artemisinin.
Since these drugs have already developed or in the process of developing drug resistance, it is important to continuously search
the plant kingdom for more eﬀective antimalarial drugs. In this aspect, the medicinal practices of indigenous communities can
play a major role in identiﬁcation of antimalarial plants. Bangladesh has a number of indigenous communities or tribes, who
because of their living within or in close proximity to mosquito-infested forest regions, have high incidences of malaria. Over
the centuries, the tribal medicinal practitioners have treated malaria with various plant-based formulations. The objective of the
present study was to conduct an ethnomedicinal survey among various tribes of Bangladesh to identify the plants that they use
for treatment of the disease. Surveys were conducted among seven tribes, namely, Bawm, Chak, Chakma, Garo, Marma, Murong,
and Tripura, who inhabit the southeastern or northcentral forested regions of Bangladesh. Interviews conducted with the various
tribal medicinal practitioners indicated that a total of eleven plants distributed into 10 families were used for treatment of malaria
and accompanying symptoms like fever, anemia, ache, vomiting, and chills. Leaves constituted 35.7% of total uses followed by
roots at 21.4%. Other plant parts used for treatment included barks, seeds, fruits, and ﬂowers. A review of the published scientiﬁc
literature showed that a number of plants used by the tribal medicinal practitioners have been scientiﬁcally validated in their uses.
Taken together, the plants merit further scientiﬁc research towards possible discovery of novel compounds that can be used to
successfully treat malaria with less undesirable sideeﬀects.
1.Introduction
According to World Health Organization (WHO), malaria
has aﬄicted human beings since antiquity [1]. The disease
is caused by a protozoan of the genus Plasmodium and
is transmitted through bites by female mosquitoes of the
genus Anopheles. Five subspecies of Plasmodium, including
P. falciparum, P. malariae, P. ovale, P. knowlesi, and P. vivax
can cause malaria, and 90% of known human deaths are
caused by P. falciparum. Plasmodium enters the blood stream
through mosquito bites, where they infect and destroy red
blood cells leading to the various symptoms of malaria,
including chills, muscle ache, fever, nausea, and vomiting,
and even coma, anemia, and severe respiratory problems. It
has been estimated that 300–500 million malaria infections
occur worldwide on an annual basis [2].
The antimalarial drug, quinine, whose use has been
documented almost 400 years ago [3], was isolated from the
bark of the Cinchona tree, which in addition also contains
three other antimalarial compounds, namely, quinidine,
cinchonine, and cinchonidine [4]. A common antimalarial
drug in use today is chloroquine, a synthetic derivative of
quinine. Use of quinine is challenged by its poor tolerability
and poor compliance with complex dosing regimens; in
addition, there have been concerns about potential interac-
tions between quinine and antiretroviral and antitubercular
drugs in human immunodeﬁciency virus and tuberculosis-
aﬀected patients [3]. Pruritus is a common adverse eﬀect of2 Malaria Research and Treatment
chloroquine administration in African patients [5]. More-
over, the drugs are rapidly losing their value as antimalarial
drugs because of emergence of drug-resistant strains of Plas-
modium. The latest antimalarial drug is artemisinin, which
is derived from the plant Artemisia annua L. (Asteraceae),
and has been used in Chinese traditional medicine for more
than 1,000 years for treatment of malaria. Artemisinin-
derived antimalarial drugs like artesunate and artelinic acid
reportedly caused embryo death and malformations in
pregnant rats by killing embryonic erythroblasts [6]. Some
ﬁndingsindicatethatP.falciparumstrainsmaybedeveloping
resistant varieties to artemisinin in China. The IC50 of
artemisinin in African strains of P. falciparum is reportedly
6–25nM, while Chinese strains have IC50 value of about 630
nM [7].
Current treatment against malaria infections include
combination therapies utilizing artemisinin or artemisinin-
derivatives and other antimalarial drugs like amodiaquine,
lumefantrine,meﬂoquine,primaquine,sulfadoxine,pyrime-
thamine, or chloroquine. As a precaution against further
development of artemisinin-resistant Plasmodium strains,
current therapeutic strategy involves use of artemisinin
only with other antimalarial drugs [8]. However, it can
be said with some certainty, that the present combination
therapies, will in due course of time and possibly within
a few years, develop drug-resistant strains of Plasmodium.
The search for antimalarial drugs thus becomes a continuous
process of developing newer drugs against already emer-
gent or possibly emerging resistant strains of Plasmodium.
Since plant kingdom has proven an eﬀective source of
antimalarial drugs in the past, and since about 1,200 plant
species are used in traditional medicines of the world for
treatment of malaria [2], these plant species may prove
to be a valuable reservoir for discovery of a continuous
series of newer eﬀective drugs against malaria. One has,
therefore, to look into the medicinal practices of indigenous
communities for information on antimalarial plants, since
indigenous communities, present in virtually all countries
of the world, have centuries-old experience about the use of
such plants and have extensive knowledge obtained through
generationsofusageonmedicinalpropertiesofvariousplant
species.
Bangladesh has a number of indigenous communities
or tribes. Some of the well-known tribes include the Chak,
Chakma, Marma, Murong, Tripura, and Bawm tribes, who
inhabit the forested regions of the Chittagong Hill Tracts in
southeastern Bangladesh. The Garos are a major tribe inhab-
iting the forested regions of the northcentral regions of the
country. Malaria is prevalent in Bangladesh with the highest
prevalence noted in the southeast, north, and northeast parts
with around 15% of the population reported as suﬀering
from malaria in these areas, especially the southeast, and
particularly among the tribal people inhabiting these regions
[9, 10]. Tribal people, till even now, frequent their own tribal
medicinal practitioners (TMPs) for treatment of malaria. It
has been reported that 60–70% of the Chakma, Marma, and
Tripura tribal people frequent their own TMPs for malaria
treatment [11]. The objective of the present study was to
conduct a survey among the TMPs of the above-mentioned
tribes to gather information on the medicinal plants used by
them for treatment of malaria.
2.MaterialsandMethods
The present survey was conducted between October 2009
and May 2011 among TMPs of Bawm, Chak, Chakma,
Marma, Murong, and Tripura tribes inhabiting Khagrachari
and Bandarban districts of Chittagong Hill Tracts region of
Bangladesh,andTMPsoftheGarotribeinhabitingadjoining
villages in Tangail and Mymensingh districts of Bangladesh.
The study protocol was approved by the Research Ethics
Committee of the University of Development Alternative.
The number of TMPs living among the Bawm, Chak,
Chakma, Marma, Murong, Tripura, and Garo communities
surveyed were, respectively, 4, 4, 7, 6, 6, 5, and 7. In total,
the number of TMPs consulted from the seven tribes was
28 (four per tribe—the authors decided to take the same
number of TMPs from each tribe, and since the Bawm
and Chak tribes had the least number of TMPs at 4, this
number was selected to be taken as the number of TMPs
to be interviewed from the other tribes also). Among tribes,
which had more than 4 serving TMPs, 4 were chosen on
the basis of the recommendation of the tribal Headman as
to being more proﬁcient in their practices. At the request
of the TMPs from any individual tribe, interviews were
conducted of the four TMPs per tribe as a group. Informed
consent was initially obtained from the TMPs and the tribal
Headman (chieftain) to gather the necessary information.
Both TMP and the Headman was apprised in details as to the
purpose of our visits, and consent obtained to disseminate
the names and formulations (if any) of antimalarial plants
both nationally and internationally. Interviews were usually
conducted through an interpreter, who can speak both the
tribal language as well as Bangla (the language spoken by
the interviewers). It may be mentioned that in recent years
most tribes have acquired suﬃcient proﬁciency in speaking
and understanding Bangla, which is the language of the
mainstream population (around 98%) of Bangladesh.
Interviewswereopen-endedandconductedwiththehelp
of a semistructured questionnaire. TMPs were speciﬁcally
asked as to whether they know and treat malaria, the basis
for their diagnosis, and their mode of treatment when
the disease has been diagnosed as malaria. The general
patterns of diagnosing malaria were more or less the same
among the TMPs of the various types. The symptoms of
malaria,accordingtotheTMPs,werefever(particularlyfever
arising daily at certain parts of the day or night followed
by subsiding and recurrence), chills, pain (throughout the
body but mostly aﬀecting the muscles or back), sweats,
fatigue, nausea, vomiting, and a general wasting away of
the body with time. TMPs were allowed to speak freely
on malarial treatment with medicinal plants with only
occasional interference and questions from the interviewers.
TMP-guided ﬁeld walks were arranged where the TMPs took
the interviewers on ﬁeld walks through areas from where the
TMPs collected the medicinal plants, pointed out the plants,
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and dried on the spot, photographed and brought back to
Dhaka for identiﬁcation by Mr. Manjur-Ul-Kadir Mia, ex-
Curator and Principal Scientiﬁc Oﬃcer of the Bangladesh
National Herbarium. Voucher specimens were deposited at
the Medicinal Plant Collection Wing of the University of
Development Alternative, where the initial identiﬁcation was
reconﬁrmed by a botanist at the Medicinal Plant Collection
Wing of the University.
3. Results
It was observed that the TMPs of the 7 tribes surveyed
used a total of 11 plants distributed into 10 families for
treatment of malaria. The Fabaceae family was the only
family contributing 2 plants; the rest of the plant families
contributed one plant each. The various plant parts used
includedleaves,roots,barks,seeds,fruits,andﬂowers.Leaves
constitutedthemajorplantpartused,forming35.7%oftotal
uses. Roots constituted 21.4% of total uses. The other plant
partsmentioned constituted,respectively,14.3,14.3,7.1,and
7.1% of total uses.
According to the TMPs of the various tribes surveyed,
their medicinal knowledge was derived from earlier gen-
eration practitioners, with whom every TMP had to serve
a period of apprenticeship and training before they could
practice independently. As such, tribal medicinal knowledge
has come out of practice through the centuries and appar-
ently every tribe had, so to say, their own lists of plants
for treatment of any particular ailment. It was therefore no
surprise that all four TMPs of any individual tribe surveyed
pointed out the same plants for treatment of malaria.
Moreover, as mentioned earlier, all 4 TMPs of any particular
tribe surveyed were interviewed as a group at their request,
and so the plants mentioned by the TMPs of a particular
tribe were the result of a general consensus among the TMPs
of the tribe and did not reﬂect any individual opinion. It
was the conclusion of the interviewers that malaria had
existed for centuries among the tribal people surveyed, and
various tribes have developed their own medicinal plant
formulations for treatment of this disease, possibly through
trial and error methods over centuries-long practices.
Any sort of complex formulations was avoided by the
TMPs for treatment of malaria. Fruits and seeds were
consumed directly or with water. In most cases, juice
obtained from squeezed plant part was advised to be taken,
or pills made from paste of plant part taken orally. In two
instances, it was noted that plant part was advised to be
taken with either black pepper or rice. A paste of roots of
Rauwolﬁa serpentina and black peppers was advised to be
taken for malaria by TMPs of the Garo tribe. Juice obtained
from roots of Amaranthus spinosus was advised to be taken
with powdered rice and water by TMPs of the Murong
tribe. Formulations were usually administered orally with
twoexceptions.TheTMPsoftheMurongtribeadvisedleaves
of the plant Mussaenda corymbosa to be boiled in water and
the malaria patient sponged and bathed in that water. The
TMPs of the Bawm tribe advised leaf infusion of the same
planttobeusedforshowerbythemalariapatient;alternately,
the patient’s body was rubbed with the infusion for a while.
Notably, this plant was exceptional from two points; not
only this plant was the only plant whose plant part (leaf)
was administered topically but also among the eleven plants
used for treatment by the seven tribes, this plant was the
only common plant to be used by two tribes—Bawm and
Murong. What is notable in this regard is that while the
Bawm, Chak, Chakma, Marma, Murong, and the Tripura
tribes inhabit adjoining forest regions containing similar
ﬂora of the same general area (Chittagong Hill Tracts), the
TMPs of these tribes use diﬀerent plants for treatment of
malaria.
Although the Chakma tribe is the major tribe of the
Chittagong Hill Tracts region, their TMPs used only 2 plants
for treatment of malaria. In contrast, the TMPs of the
Murong and the Tripura tribes used three plants each for
treatment. While the medicinal plants were advised to be
usedbytheTMPsofsixtribestobeusedforacertainnumber
of days (usually 7) or till cure, the Chak TMPs provided a
total exception to this rule. Their method for treatment of
malaria was to take 3 powdered seeds of Caesalpinia nuga
with water only once. The Chak TMPs claimed that a single
administration of the seeds of the above plant was suﬃcient
to cure malaria irrespective of its severity or duration (see
Table 1).
4. Discussion
It is always of interest to determine whether the plants
used by traditional medicinal practitioners for treatment
of various ailments can be validated through existing sci-
entiﬁc studies. Towards that, available scientiﬁc literature
was screened for reports that may validate the use of the
antimalarialplantsoftheseventribessurveyed.Procyanidins
have been isolated from fruits of Adansonia digitata [12];
a number of procyanidins have been reported to possess
antiplasmodial activity [13–16]. Scoparia dulcis, similar to
its antimalarial usage by the Murong TMPs in Bangladesh,
is also used by native Amazonian groups from the Nanay
River (Peru) for treatment of malaria [17]. Scopadulcic acid
A has been isolated from the plant, which has been found
to inhibit P. falciparum strains D6 and W2 in vitro with
IC50 values of 27 and 19µM, respectively. The compound
has further been shown to be active against the multidrug-
resistant strain TM91C235 with an IC50 value of 23µM[ 18].
ExtractofStreblusasper reportedlyexhibitedantimalarial
propertiesagainstmurinemalaria[19].Lupeolandoleanolic
acids have been reported from leaves and aerial parts
of the plant [20, 21]. Lupeol and lupeol-derivatives have
been reported to possess antiplasmodial activity accord-
ing to a number of reports [22–24]. Oleanolic acid has
also been reported to possess antiplasmodial activity. Epi-
oleanolic acid has been isolated through bioactivity-guided
fractionation of whole plant of Viola verecunda with high
antiplasmodial activity against chloroquine-resistant FcB1
strain of P. falciparum with an IC50 value of 0.18µg/mL [25].
Although any scientiﬁc report is absent on the anti-
malarial properties of Caesalpinia nuga, other species from4 Malaria Research and Treatment
Table 1: Medicinal plants used by various tribes of Bangladesh for treatment of malaria and accompanying symptoms.
Serial
number Botanical name Family Local name
(tribe) Parts used Dosage
1 Caesalpinia nuga (L.) W. T.
Aiton Fabaceae Krung-khai
(Chak) Seed
Three seeds are powdered mixed
with water and taken only once
for cure.
2 Adansonia digitata L. Bombacaceae Kattio-daghor
(Chakma)
Leaf, root,
ﬂower
A combination of leaves, roots,
and ﬂowers is taken till cure.
3 Jatropha gossypifolia L. Euphorbiaceae Titto-long
(Chakma) Seed Seeds are taken with water till
cure.
4 Rauwolﬁa serpentina Benth. Apocynaceae Sharpagandha
(Garo) Root
A paste of root and black pepper
is administered (dose equal to
4-5 ratis, 1 rati = 1 tola = 11.66g)
till cure.
5 Hodgsonia macrocarpa Cogn. Cucurbitaceae Keha-pang
(Marma) Fruit The fruits are taken till cure.
6 Erythrina variegata L. Fabaceae
Mada-kamia-
mafang
(Tripura)
Bark Bark paste is made into pills and
the pills taken till cure.
7 Streblus asper Lour. Moraceae Sarwa (Tripura) Bark Juice obtained from squeezed
bark is taken till cure.
8 Clerodendrum viscosum Vent. Verbenaceae Kung-sroi-ma
(Tripura) Leaf One teaspoonful leaf juice is
taken 3 times daily for a week.
9 Amaranthus spinosus L. Amaranthaceae Kang-chuo
(Murong) Root
Juice obtained from squeezed
roots is mixed with powdered
rice and taken with water till
cure.
10
Mussaenda corymbosa A.L. de
Jussieu
Rubiaceae
Mok-ae
(Murong) Leaf
Leaves are boiled thoroughly in
water. The patient is both
sponged and bathed in the water
till cure.
Thalepat harkep
(Bawm) Leaf
Leaf infusion is taken for shower
or whole body rubbed with the
infusion for a while every day till
cure.
11 Scoparia dulcis L. Scrophulariaceae Tapra-amkanlu
(Murong) Leaf
Juice squeezed from leaves is
taken two teaspoon full daily in
the morning and evening for 7
days or till cure.
the same genus are reported to contain phytochemical
constituents with strong antiplasmodial activities. Cassane
and norcassane-type diterpenes are in general present in the
Caesalpinia genus. Three cassane furano diterpenoids, all
with good activity against multidrug-resistant K1 strain of P.
falciparum, have been reported from seed kernels of C. bon-
duc [26]. Methyl chloride extract of seed kernels of C. crista
L. reportedly demonstrated promising antimalarial activity
against P. berghei-infected mice in vivo. Chemical analysis
of the extract resulted in the isolation of furanocassane-
type diterpenes. The isolated diterpenes showed signiﬁcant
inhibitory eﬀects on P. falciparum FCR-3/A2 growth in vitro,
with IC50 values ranging from 90nM to 6.5µM. Among
the isolated diterpenes, norcaesalpinin E had the lowest
IC50 concentration at 90nM [27]. Norcaesalpinin E has also
been reported to possess the most potent activity against
P. falciparum FCR-3/A2 clone in vitro among 44 cassane-
and norcassane-type diterpenes isolated from C. crista of
Myanmar and Indonesia [28].
The available scientiﬁc literature strongly suggests that
at least some of the plants used by the TMPs of various
tribes of Bangladesh may have strong scientiﬁc basis for
their use in the treatment of malaria. It may be pointed
out in this regard that since malaria has aﬀected human
beings from antiquity, medical practitioners of various tribes
and later nations have used various remedies to treat the
disease. Medicinal plants have formed possibly the strongest
component of such antimalarial remedies. Also the history
of long usage of such medicinal plants for treatment of
malaria by TMPs of Bangladesh indicates that these plants
have proved to a greater or lesser extent successful in the
treatment of malaria and/or associated symptoms. Taken
together, the eleven medicinal plants used by the TMPs
of Bangladesh merits further research towards discovery ofMalaria Research and Treatment 5
novel and eﬃcacious antimalarial drugs. C. nuga can be
taken as a prime example to work upon. While this plant is
yet to be studied scientiﬁcally, other species from the same
genus reportedly contains strong antimalarial constituents.
It is also noteworthy that the TMPs use a single dose of
the seeds of this plant to treat malaria, suggesting that
the seeds may contain some very eﬀective antimalarial or
antiplasmodial compounds. Antiplasmodial and cytotoxicity
studies on the various antimalarial plants and plant parts
need to be carried out and will be done in the next phase
of this study.
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